Email has been sent
You will receive this within the next few minutes.
Investment objective: Invests principally in blue chip equities in those countries which are members of the Economic Monetary Union (EMU) and primarily denominated in Euro. Currently, these are the nineteen member countries but if... Read more
Fund size: 836.50m
|A-EUR share class||-4.8||12.4||4.1||21.1||31.4|
|YTD||1 mth||3 mths||6 mths||1 yr||3 yrs||5 yrs||10 yrs||Since launch|
|A-EUR share class||12.1||2.8||10.5||16.7||13.9||18.4||88.2||25.2||163.0|
|With 5.00% sales charge||6.5||-2.3||4.9||10.8||8.2||12.5||78.8||18.9||149.9|
|1 yr||3 yrs||5 yrs||Since launch|
|A-EUR share class||13.9||5.8||13.5||5.3|
|With 5.00% sales charge||8.2||4.0||12.3||5.0|
|Portfolio manager||Alexandra Hartmann|
|Fund launch date||30 Sep 1998|
|Share class launch date||30 Sep 1998|
|Annual management fee||1.50%|
|Max. sales charge - cash||5.25%|
|(As of 31/05/2017)|
Fund data as of 31/05/2017 unless otherwise stated.
Performance data are computed on NAV-NAV basis with dividend reinvested, and in the respective currency terms as stated. Past performance is not indicative of the future returns.
All Fund prices quoted are calculated as at the latest valuation date. They are not indicative of the likely trend or price of the Fund(s) in the future. Investors investing in Fund(s) denominated in non-local currency should be aware of exchange rate fluctuations that may cause a loss of principal when foreign currency is converted back to the investors' home currency. Exchange controls may be applicable from time to time to certain foreign currencies.
Please refer to the prospectus for details of the investment objectives and risks associated with the Fund(s) mentioned. This document is for general circulation only and it does not have regard to the specific investment objectives, financial situation and particular needs of any specific person who may receive it. You should seek advice from a financial adviser before investing in the Fund(s). If you choose not to seek advice from a financial adviser, you should consider whether the Fund(s) in question is suitable for you. This document cannot be construed as an advice or recommendation.
FIL Investment Management (Singapore) Limited [“FIMSL”] (Co. Reg. No.: 199006300E) is the representative for the Fund(s) offered in Singapore. Potential investors should read the prospectus, available from FIMSL or its distributors, before investing in the Fund(s). The value of the shares of the Fund(s) and the income accruing to them, if any, may fall or rise. The Fund(s) may use financial derivatives, which entail specific risks as described in the prospectus.
References to specific securities are for illustrative purposes only and should not be construed as recommendation or advice to transact in them.
Please note that the information provided is as of the stated date and may subsequently change in the future without prior notice.
Please note that the dividend rate of the Fund does not represent its total return. The dividends are not guaranteed and may vary from time to time. For certain Classes of Shares, dividends may be paid out of capital where the income/capital gain generated by the Fund is insufficient to pay a distribution as declared. Investors should note that the payment of dividends out of capital represents a return or withdrawal of part of the amount they originally invested or from any capital gains attributable to the original investment. Such distributions may result in an immediate decrease in the net asset value per Share of the Fund.
Stocks were lackluster Friday closing mixed for the third straight day. The Dow Jones industrials slipped 2.53 points while the S&P added 0.2 percent and the Nasdaq was 0.5 percent higher. For the week, the Nasdaq gained 1.8 percent while the S&P edged up 0.2 percent and the Dow added10.48 points. Traders remained reluctant to make significant moves amid uncertainty about the near-term outlook for the markets.
Stocks were little changed in the US on Thursday. The Dow Jones industrials and the S&P each slipped 0.1 percent while the Nasdaq was virtually unchanged (up 2.73 points). Healthcare stocks advanced after Republicans unveiled a bill to repeal Obamacare and oil prices rose from multi-month lows and relieved some of the pressure on energy stocks. A recent surge in biotechnology shares showed no signs of slowing. With the end of the second quarter just a week away, investors are beginning to look forward to the July 4 holiday followed by the beginning of the earnings season.